Long-Term Debt: The sum of all long term debt fields.
Agios Pharmaceuticals, Inc. (AGIO) Long-Term Debt data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$44.74M |
|
$-100.70M |
|
$3.00M |
|
$41.75M |
|
$155.30M |
|
$-110.55M |
|
$9.85M |
|
$-100.70M |
|
$-100.70M |
|
$-100.70M |
|
$-100.70M |
|
$-100.70M |
|
$-100.70M |
|
$-110.55M |
|
$-110.33M |
|
59.49M |
|
59.49M |
|
$-1.69 |
|
$-1.69 |
|
| Balance Sheet Financials | |
$717.67M |
|
$9.95M |
|
$390.76M |
|
$1.11B |
|
$70.22M |
|
|
Long-Term Debt |
-- |
$12.19M |
|
$82.40M |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
59.60M |
|
| Cash Flow Statement Financials | |
$-176.23M |
|
$181.52M |
|
$5.23M |
|
$89.13M |
|
$99.65M |
|
$10.52M |
|
$31.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.30% |
|
-247.07% |
|
-247.07% |
|
-- |
|
-225.06% |
|
-225.06% |
|
$-178.21M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.10 |
|
2.22 |
|
40.45 |
|
-9.81% |
|
-9.81% |
|
-9.09% |
|
-9.81% |
|
$17.21 |
|
$-3.00 |
|
$-2.96 |
|